(Q35856884)

10 August 2017

1 reference

title

High-density lipoprotein subfractions and risk of coronary artery disease (English)

1 reference

10 August 2017

coronary artery disease

1 reference

John Morgan

1

1 reference

10 August 2017

Christina Carey

series ordinal

2

1 reference

10 August 2017

Anne Lincoff

series ordinal

3

1 reference

10 August 2017

David Capuzzi

series ordinal

4

1 reference

10 August 2017

1 September 2004

1 reference

Current Atherosclerosis Reports

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

5

1 reference

10 August 2017

359-365

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-004-0047-0

10 August 2017

0 references

cites work

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0047-0

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0047-0

Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0047-0

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0047-0

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

12 December 2020

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial

1 reference

12 December 2020

Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients

1 reference

12 December 2020

Nonpharmacologic management of low levels of high-density lipoprotein cholesterol

1 reference

12 December 2020

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

12 December 2020

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update

1 reference

12 December 2020

Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease

1 reference

12 December 2020

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

1 reference

12 December 2020

Familial hypoalphalipoproteinemia in premature coronary artery disease

1 reference

12 December 2020

Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Effects of extended-release niacin on lipoprotein subclass distribution

1 reference

12 December 2020

Reverse cholesterol transport: high-density lipoprotein's magnificent mile

1 reference

12 December 2020

Lipoprotein heterogeneity: diagnostic and therapeutic implications

1 reference

12 December 2020

The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease

1 reference

12 December 2020

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

1 reference

12 December 2020

Mechanism of action of niacin on lipoprotein metabolism

1 reference

12 December 2020

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL(3) cholesterol

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men

1 reference

12 December 2020

Change in alpha1 HDL concentration predicts progression in coronary artery stenosis

1 reference

12 December 2020

Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities

1 reference

12 December 2020

Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

1 reference

12 December 2020

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

12 December 2020

Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

1 reference

12 December 2020

Measurement issues related to lipoprotein heterogeneity

1 reference

12 December 2020

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

12 December 2020

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance

1 reference

12 December 2020

The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease

1 reference

12 December 2020

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

12 December 2020

Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis

1 reference

12 December 2020

High-density lipoprotein subpopulations in pathologic conditions

1 reference

12 December 2020

Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study

1 reference

12 December 2020

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

1 reference

12 December 2020

10.1007/S11883-004-0047-0

Identifiers

DOI

1 reference

10 August 2017

1 reference